CI Canadian Convertivle ...【CXF】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
ETF
カナダ
TSX
CI Canadian Convertivle Bond ETF (CXF) 銘柄情報

CI Canadian Convertivle Bond ETF (CXF)

10.20

0.05

( 0.49% )

更新日時： 01:58:20

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

10.20

買値

10.20

売値

10.32

出来高

6,801

10.11 日の範囲 10.28

0.00 52 週間の範囲 0.00

時価総額

前日終値

10.15

始値

10.11

時刻

最終取引時間

01:58:20

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

-

配当利回り

-

PER

0.00

1 株当たり利益 (EPS)

-

歳入

2.84M

純利益

2.42M

セクター

Unit Inv Tr, Closed-end Mgmt

業界

Unit Inv Tr, Closed-end Mgmt

ウェブサイト

www.firstasset.com

本社

Toronto, Ontario, Can

設立

-

CI Canadian Convertivle Bond ETF is listed in the Unit Inv Tr, Closed-end Mgmt sector of the トロント証券取引所 with ticker CXF. The last closing price for CI Canadian Convertivle ... was $10.15. Over the last year, CI Canadian Convertivle ... shares have traded in a share price range of $ 0.00 to $ 0.00.

CI Canadian Convertivle ... currently has 0 shares in issue.

Gestion mondiale d’actifs CI récompensée par 16 prix LSEG Lipper Fund

Pour la deuxième année consécutive, GMA CI remporte le plus grand nombre de récompenses du secteur Gestion mondiale d’actifs CI (« GMA CI ») annonce que ses fonds d’investissement ont remporté...

Les fonds d'investissement de Gestion mondiale d’actifs CI honorés pour leur rendement exceptionnel

Gestion mondiale d’actifs CI (« GMA CI ») annonce qu’elle a reçu 39 prix FundGrade A+® pour l’année 2022. Les fonds gagnants de GMA CI comprennent 16 fonds communs de placement et fonds négociés...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ERNAEterna Therapeutics Inc	US$ 0.6922 (124.01%)	484.84M
NMHINatures Miracle Holding Inc	US$ 2.3499 (107.96%)	145.24M
HEESH and E Equipment Services Inc	US$ 90.3028 (105.51%)	8.56M
AIFFFirefly Neuroscience Inc	US$ 3.687 (94.05%)	110.26M
SPISPI Energy Company Ltd	US$ 1.27 (48.52%)	29.32M
PHIOPhio Pharmaceuticals Corporation	US$ 3.35 (-49.24%)	8.8M
MBIOMustang Bio Inc	US$ 0.1416 (-36.76%)	11.62M
SLRXSalarius Pharmaceuticals Inc	US$ 2.59 (-29.43%)	1.44M
AEHRAehr Test Systems	US$ 11.41 (-28.64%)	3.9M
AVGRAvinger Inc	US$ 0.5898 (-26.56%)	1.08M
ERNAEterna Therapeutics Inc	US$ 0.6933 (124.37%)	484.86M
RGTIRigetti Computing Inc	US$ 6.9346 (14.62%)	183.96M
NMHINatures Miracle Holding Inc	US$ 2.37 (109.73%)	145.3M
GCTKGlucoTrack Inc	US$ 0.1301 (-13.09%)	118.67M
AIFFFirefly Neuroscience Inc	US$ 3.70 (94.74%)	110.27M

stock_observer_77

stock_observer_77 3分前

Watching but afraid to buy.....it may hit weekly MA8

subslover

subslover 3分前

Wow, I forgot all about this pretty baby! Thank you for waking me up. Papi always takes care of his friends.🤩😇

QueenVic

QueenVic 3分前

Yup.I hear ya!
As I say about them ppl ...

Ignorance is a bliss.
And they have 🐷 💩 narratives and theories.

getmoreshares

getmoreshares 3分前

m0n

Due to the halt LoL. Blame Canada $TWOH

netmoney1999

netmoney1999 3分前

LOL so this thing is deep down in trips at a 52wk+ low and you're still pumping. Oh, and its back to .0004
💩💩💩

Horseman Country

Horseman Country 3分前

https://investorshub.advfn.com/uimage/uploads/2025/1/14/mmbclIMG_1058.jpeg

Mufaso

It's not just what Brian Lian said, but also what Big Pharma CEOs are saying. For instance, PFE's CEO Albert Bourla said on yesterday's JPM webcast that it's "a little late" to be developing an injected GLP-1-based therapy. PFE wants oral molecules and/or non-GLP-1 mechanisms. (There was no update o

IB_

After years and YEARS of "topping off" and "buying the dips" what will your 36,000 shares of ELTP be worth when Elite is doing $200 + million in fiscal 2026, 👸 ?????????????????????

IB_🤴

Monksdream

Monksdream 4分前

Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. It offers Brain Network Analytics (BNA) platform, a software as a medical solution for the diagnostic and treatment

m0n

the day $TWOH was halted on the CSE the volume was 19milky. The second highest volume on that day was over half the volume of $TWOH.

It's stupid a CSE halt affects the USA side of things. Either way, on the 10th business day, FINRA can lift the halt here which will be Thursday but f

ma snart

ma snart 4分前

You know Hunter that you and I own more shares than has been traded on a daily basis for months now, this is gonna slowly make us rich and its so funny that people on the sidelines are going to wait till we are much higher to buy in so they will be "certain" in their investments,,, we will be laughi

Horseman Country

Horseman Country 5分前

https://investorshub.advfn.com/uimage/uploads/2025/1/14/mmbclIMG_1058.jpeg

DeafTrader2

DeafTrader2 5分前

This R/S will not harm investors ...

MRc2

3331

You always say read this or that, but never provide a specific answer. Obviously, you can't. DO BETTER!

Ftor

what time is Bill Acman's presentation on Jan 16th? And how to watch it?

thanks in advance

waterchaser

waterchaser 6分前

Mining is one of the biggest scams on the OTC.

MJ is a close second... so I'm guessing HIRU will become a weed stock at some point.

12x

The omission in the PR is glaring, and it’s hard not to wonder if the company is intentionally withholding information from investors.

That’s the most disappointing part. This is an investment conference—an ideal platform to highlight key achievements. With the MAA accepted and a peer

Jetmek_03052

Jetmek_03052 6分前

Very interested.

I'm always interested in exposing a company that regularly promises its investors success but never delivers.

DBMM is a PRIME example of such a company.

The next Q coming out will simply be more proof that DBMM is a failure at its busines

DeafTrader2

DeafTrader2 6分前

To achieve these objectives, we require an increase in the authorized shares of Comstock Inc. To that end, we are convening a special meeting on February 14, 2025 , where shareholders will be asked to vote on a proposal that effectively increases our authorized shares – including a reverse stock

CI Canadian Convertivle ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約